These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 12937299)

  • 1. A fully human monoclonal antibody (CR002) identifies PDGF-D as a novel mediator of mesangioproliferative glomerulonephritis.
    Ostendorf T; van Roeyen CR; Peterson JD; Kunter U; Eitner F; Hamad AJ; Chan G; Jia XC; Macaluso J; Gazit-Bornstein G; Keyt BA; Lichenstein HS; LaRochelle WJ; Floege J
    J Am Soc Nephrol; 2003 Sep; 14(9):2237-47. PubMed ID: 12937299
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antagonism of PDGF-D by human antibody CR002 prevents renal scarring in experimental glomerulonephritis.
    Ostendorf T; Rong S; Boor P; Wiedemann S; Kunter U; Haubold U; van Roeyen CR; Eitner F; Kawachi H; Starling G; Alvarez E; Smithson G; Floege J
    J Am Soc Nephrol; 2006 Apr; 17(4):1054-62. PubMed ID: 16510766
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PDGF-D inhibition by CR002 ameliorates tubulointerstitial fibrosis following experimental glomerulonephritis.
    Boor P; Konieczny A; Villa L; Kunter U; van Roeyen CR; LaRochelle WJ; Smithson G; Arrol S; Ostendorf T; Floege J
    Nephrol Dial Transplant; 2007 May; 22(5):1323-31. PubMed ID: 17308324
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of a novel PDGF isoform, PDGF-C, in normal and diseased rat kidney.
    Eitner F; Ostendorf T; Van Roeyen C; Kitahara M; Li X; Aase K; Gröne HJ; Eriksson U; Floege J
    J Am Soc Nephrol; 2002 Apr; 13(4):910-917. PubMed ID: 11912250
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel, dual role of CCN3 in experimental glomerulonephritis: pro-angiogenic and antimesangioproliferative effects.
    van Roeyen CR; Boor P; Borkham-Kamphorst E; Rong S; Kunter U; Martin IV; Kaitovic A; Fleckenstein S; Perbal B; Trautwein C; Weiskirchen R; Ostendorf T; Floege J
    Am J Pathol; 2012 May; 180(5):1979-90. PubMed ID: 22538190
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mesangial cell expression of proto-oncogene Ets-1 during progression of mesangioproliferative glomerulonephritis.
    Raffetseder U; Wernert N; Ostendorf T; van Roeyen C; Rauen T; Behrens P; Floege J; Mertens PR
    Kidney Int; 2004 Aug; 66(2):622-32. PubMed ID: 15253715
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CCN3 is a novel endogenous PDGF-regulated inhibitor of glomerular cell proliferation.
    van Roeyen CR; Eitner F; Scholl T; Boor P; Kunter U; Planque N; Gröne HJ; Bleau AM; Perbal B; Ostendorf T; Floege J
    Kidney Int; 2008 Jan; 73(1):86-94. PubMed ID: 17914348
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of simvastatin on proliferative nephritis and cell-cycle protein expression.
    Yoshimura A; Nemoto T; Sugenoya Y; Inui K; Watanabe S; Inoue Y; Sharif S; Yokota N; Uda S; Morita H; Ideura T
    Kidney Int Suppl; 1999 Jul; 71():S84-7. PubMed ID: 10412745
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Heparin suppresses mesangial cell proliferation and matrix expansion in experimental mesangioproliferative glomerulonephritis.
    Floege J; Eng E; Young BA; Couser WG; Johnson RJ
    Kidney Int; 1993 Feb; 43(2):369-80. PubMed ID: 8441232
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of interleukin-1 in mesangial cell proliferation and matrix deposition in experimental mesangioproliferative nephritis.
    Tesch GH; Lan HY; Atkins RC; Nikolic-Paterson DJ
    Am J Pathol; 1997 Jul; 151(1):141-50. PubMed ID: 9212740
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A phase I study of CR002, a fully-human monoclonal antibody against platelet-derived growth factor-D.
    Hawthorne T; Giot L; Blake L; Kuang B; Gerwien R; Smithson G; Hahne W; Mansfield T; Starling GC; Pochart P; Hoelscher D; Halvorsen YD
    Int J Clin Pharmacol Ther; 2008 May; 46(5):236-44. PubMed ID: 18538109
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effects of platelet-derived growth factor antagonism in experimental glomerulonephritis are independent of the transforming growth factor-beta system.
    Ostendorf T; Kunter U; van Roeyen C; Dooley S; Janjic N; Ruckman J; Eitner F; Floege J
    J Am Soc Nephrol; 2002 Mar; 13(3):658-667. PubMed ID: 11856769
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of PDGF-D in mesangioproliferative glomerulonephritis.
    Floege J; van Roeyen C; Boor P; Ostendorf T
    Contrib Nephrol; 2007; 157():153-8. PubMed ID: 17495455
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Signal transduction involved in protective effects of 15(R/S)-methyl- lipoxin A(4) on mesangioproliferative nephritis in rats.
    Wu SH; Wu XH; Liao PY; Dong L
    Prostaglandins Leukot Essent Fatty Acids; 2007 Mar; 76(3):173-80. PubMed ID: 17329090
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PDGF signal transduction inhibition ameliorates experimental mesangial proliferative glomerulonephritis.
    Gilbert RE; Kelly DJ; McKay T; Chadban S; Hill PA; Cooper ME; Atkins RC; Nikolic-Paterson DJ
    Kidney Int; 2001 Apr; 59(4):1324-32. PubMed ID: 11260393
    [TBL] [Abstract][Full Text] [Related]  

  • 16. C-type natriuretic peptide inhibits mesangial cell proliferation and matrix accumulation in vivo.
    Canaan-Kühl S; Ostendorf T; Zander K; Koch KM; Floege J
    Kidney Int; 1998 May; 53(5):1143-51. PubMed ID: 9573528
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multi-glycoside of Tripterygium wilfordii Hook f. ameliorates proteinuria and acute mesangial injury induced by anti-Thy1.1 monoclonal antibody.
    Wan Y; Gu L; Suzuki K; Karasawa T; Fujioka Y; Han GD; Koike H; Kawachi H; Shimizu F
    Nephron Exp Nephrol; 2005; 99(4):e121-9. PubMed ID: 15722645
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Extracellular actin impairs glomerular capillary repair in experimental mesangioproliferative glomerulonephritis.
    Janssen U; Eitner F; Kunter U; Ostendorf T; Wolf G; Chaponnier C; Gabbiani G; Kerjaschki D; Floege J
    Nephron Exp Nephrol; 2003; 93(4):e158-67. PubMed ID: 12759577
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Upregulation of cyclooxygenase-1 and the PGE2 receptor EP2 in rat and human mesangioproliferative glomerulonephritis.
    Hartner A; Pahl A; Brune K; Goppelt-Struebe M
    Inflamm Res; 2000 Jul; 49(7):345-54. PubMed ID: 10959556
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rat glomerular mesangial cells synthesize basic fibroblast growth factor. Release, upregulated synthesis, and mitogenicity in mesangial proliferative glomerulonephritis.
    Floege J; Eng E; Lindner V; Alpers CE; Young BA; Reidy MA; Johnson RJ
    J Clin Invest; 1992 Dec; 90(6):2362-9. PubMed ID: 1361494
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.